Item 5.07. Submission of Matters to a Vote of Security Holders.

The proposals set forth below were submitted to the stockholders at the Annual Meeting of Stockholders (the "Annual Meeting") of Aura Biosciences, Inc. (the "Company") held on June 7, 2023, with each such proposal described in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 25, 2023.

The number of shares of common stock entitled to vote at the Annual Meeting was 37,800,102. The number of shares of common stock present or represented by valid proxy at the Annual Meeting was 25,731,072. The number of votes cast for and against and the number of abstentions and broker non-votes with respect to each proposal voted upon are set forth below.

Proposal 1 - Election of Directors

The Company's stockholders elected the two (2) director nominees below to the Company's Board of Directors as Class II directors to hold office until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified.



                                                           Broker
Director Nominee    Votes For        Votes Withheld       Non-Votes
David Johnson        13,248,297            3,275,812       9,206,963
Karan Takhar         13,248,607            3,275,502       9,206,963

Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm

The Company's stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023.



Votes For    Votes Against   Abstentions
25,725,525       3,721          1,826

There were zero broker non-votes regarding this proposal.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses